Skip to content

Time Performance of Scoop Stretcher Versus Vacuum Mattress for Prehospital Spinal Stabilization

Time Performance of Scoop Stretcher Versus Vacuum Mattress for Prehospital Spinal Stabilization: Open-Label Simulation-based Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04904770
Enrollment
15
Registered
2021-05-27
Start date
2021-06-10
Completion date
2021-09-30
Last updated
2026-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immobilization

Keywords

Spinal stabilization, Prehospital, Emergency Medical Services, Scoop stretcher, Vacuum mattress, Spinal cord injury, Prehospital emergency care

Brief summary

A simulation-based randomized controlled trial was designed with the objective to assess the time needed to achieve spinal stabilization using a scoop stretcher compared to a vacuum mattress.

Detailed description

A simulation-based randomized controlled trial was designed with the objective to assess the time needed to achieve spinal stabilization using a scoop stretcher compared to a vacuum mattress. The participants will be recruited among healthcare workers from one Emergency Medical Service. Then, the participants will first act as patient and undergo spinal stabilization from an other team, afterwards they will have to complete a spinal stabilization either using a scoop stretcher or a vacuum mattress, depending on allocation regarding randomization. The sessions will be video recorded to allow subsequent assessment.

Interventions

Already included in arm/group description

Already included in arm/group description

Sponsors

Stuby Loric
Lead SponsorOTHER
Geneve TEAM Ambulances
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Due to nature of therapy, it is impossible to mask participants, care provider, investigators or outcomes assessors. Statistician will however be blinded to allocation.

Intervention model description

Randomized Controlled Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* registered paramedics or emergency medical technician (EMT) actually working in the ambulance service.

Exclusion criteria

* member of study investigators

Design outcomes

Primary

MeasureTime frameDescription
Change in Time to Perform the ProcedureAt study session (real-time assessment), in July or AugustThe time required to complete the procedure from the team leader's order to start, until the device is left up from the ground, measured in seconds.

Secondary

MeasureTime frameDescription
Quality of StabilizationAt study session (real-time assessment), in July or AugustQuality of stabilization (accuracy of tightening of restraints belts) regarding the standard operating procedure, in a dichotomous manner (sufficient vs insufficent).
Level of Anxiety5 minutes after spinal stabilization, on a questionnaireParticipants will estimate their level of anxiety on a visual analog scale from 0 = "No anxiety at all" to 10 = "The worst anxiety imaginable".
Level of Comfort5 minutes after spinal stabilization, on a questionnaireParticipants will estimate their level of comfort on a visual analog scale from 0 = "Very, very comfortable" to 10 = "Very, very uncomfortable".
Degree of Induced Dyspnoea or Shortness of Breath5 minutes after spinal stabilization, on a questionnaireParticipants will estimate their degree of induced dyspnoea or shortness of breath on a visual analog scale from 0 = "No dyspnoea or shortness of breath" to 10 = "The worst imaginable dyspnoea".

Countries

Switzerland

Contacts

PRINCIPAL_INVESTIGATORLoric Stuby

Geneve TEAM Ambulances

Baseline characteristics

Characteristic
Age, Continuous31 years
Race and Ethnicity Not Collected0 Participants
Sex/Gender, Customized
Man
8 Participants
Sex/Gender, Customized
Other
1 Participants
Sex/Gender, Customized
Woman
4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 7
other
Total, other adverse events
0 / 80 / 7
serious
Total, serious adverse events
0 / 80 / 7

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 10, 2026